Tara Bancroft
Stock Analyst at TD Cowen
(2.98)
# 1,576
Out of 5,105 analysts
10
Total ratings
75%
Success rate
28.78%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Tara Bancroft
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| OCUL Ocular Therapeutix | Maintains: Buy | $14 → $20 | $14.56 | +37.36% | 4 | Oct 30, 2025 | |
| LNTH Lantheus Holdings | Maintains: Buy | $95 → $80 | $66.62 | +20.08% | 1 | Sep 15, 2025 | |
| TGTX TG Therapeutics | Initiates: Buy | $50 | $31.35 | +59.49% | 1 | Oct 29, 2024 | |
| PTGX Protagonist Therapeutics | Initiates: Buy | $65 | $95.35 | -31.83% | 1 | Sep 24, 2024 | |
| GERN Geron | Initiates: Buy | $10 | $1.36 | +635.29% | 1 | Apr 29, 2024 | |
| MRUS Merus | Initiates: Outperform | n/a | $96.93 | - | 1 | Aug 21, 2023 | |
| BCYC Bicycle Therapeutics | Initiates: Outperform | n/a | $7.45 | - | 1 | Aug 31, 2022 |
Ocular Therapeutix
Oct 30, 2025
Maintains: Buy
Price Target: $14 → $20
Current: $14.56
Upside: +37.36%
Lantheus Holdings
Sep 15, 2025
Maintains: Buy
Price Target: $95 → $80
Current: $66.62
Upside: +20.08%
TG Therapeutics
Oct 29, 2024
Initiates: Buy
Price Target: $50
Current: $31.35
Upside: +59.49%
Protagonist Therapeutics
Sep 24, 2024
Initiates: Buy
Price Target: $65
Current: $95.35
Upside: -31.83%
Geron
Apr 29, 2024
Initiates: Buy
Price Target: $10
Current: $1.36
Upside: +635.29%
Merus
Aug 21, 2023
Initiates: Outperform
Price Target: n/a
Current: $96.93
Upside: -
Bicycle Therapeutics
Aug 31, 2022
Initiates: Outperform
Price Target: n/a
Current: $7.45
Upside: -